| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Aug 12, 2024 | Option Exercise | $89.09 | 20,725 | 1,846,429 | 34,906 | Aug 14, 2024, 04:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Aug 12, 2024 | Sale | $270.99 | 22,025 | 5,968,516 | 33,485 | Aug 14, 2024, 04:12 PM | |
| ALNY | ALNYLAM PHARMACEUTICALS, INC. | Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | Jun 25, 2024 | Sale | $230.99 | 1,198 | 276,731 | 15,334 | Jun 26, 2024, 04:26 PM |
Menu